World Hemophilia Day: History and Significance Medical Dialogues Bureau16 April 2022 1:05 PM ISTNew Delhi: World Hemophilia Day is observed on April 17 every year by the World Federation of Hemophilia. It is an awareness day for hemophilia and...
Gene therapy found effective in Severe Hemophilia A in Phase 3 Study in Adults Dr. Kamal Kant Kohli15 Jan 2022 9:00 AM ISTSAN RAFAEL: A phase 3 study evaluating valoctocogene roxaparvovec, an investigational adeno-associated virus (AAV) gene therapy, in adults with severe...
Prophylaxis fitusiran may improve QoL and decrease bleeding in hemophilia patients: ATLAS-INH trial MD Editorial Team20 Dec 2021 9:00 AM ISTDelhi: The effectiveness of fitusiran 80 mg monthly subcutaneous prophylaxis in persons with hemophilia A or B with inhibitors was proven in Phase 3...
Novel gene therapy for hemophilia may help eliminate life-threatening bleeding events Hina Zahid22 Nov 2021 7:00 AM ISTA novel gene therapy for hemophilia A led to sustained expression of the clotting factor those patients lack, resulting in a reduction – or in some...
World Hemophilia day: 80 per cent cases undiagnosed in India Medical Dialogues Bureau17 April 2019 9:45 AM ISTCurrently, only about 20,000 patients are registered with Hemophilia Federation of India while over 1.5 lakh are still not brought under the registry...
FDA approves Baxalta's drug Adynovate for rare bleeding disorder Meghna A Singhania15 Nov 2015 3:51 PM ISTThe U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged...
